Entegris, Inc. — 2016 Form 10-K Summary
Business context and reporting period. Entegris develops and supplies specialty chemicals, advanced materials-handling products, and contamination-control solutions, principally for semiconductor manufacturing. Its three segments are Specialty Chemicals and Engineered Materials (SCEM), Advanced Materials Handling (AMH), and Microcontamination Control (MC). The filing covers the fiscal year ended December 31, 2016; fourth-quarter results are also summarized below. The company reported that semiconductor demand and fab utilization improved during 2016.
Financial performance
| Metric | FY 2016 | FY 2015 |
|---|---|---|
| Net sales | $1,175.3 million | $1,081.1 million |
| Gross profit / margin | $508.7 million / 43.3% | $470.2 million / 43.5% |
| Operating income / margin | $155.5 million / 13.2% | $118.1 million / 10.9% |
| Net income | $97.1 million | $80.3 million |
| Diluted EPS | $0.68 | $0.57 |
| Cash from operations | $207.6 million | $120.9 million |
| Capital expenditures | $65.3 million | $72.0 million |
- Annual sales increased 9%; excluding $13.8 million of favorable currency translation, management reported 7% growth. Higher volume was the principal driver and selling-price erosion was described as nominal.
- Gross margin was 43.3%, versus 43.5%. FY 2016 included $6.3 million of equipment impairment and severance charges; excluding these, management reported a 43.8% margin.
- Adjusted EBITDA, a non-GAAP measure, was $263.7 million (22.4% of sales), compared with $232.4 million (21.5%) in 2015. Non-GAAP EPS was $0.94 versus $0.85. These measures exclude specified items; they are not substitutes for GAAP results.
- Fourth quarter: sales were $308.5 million, versus $266.8 million in Q4 2015; operating income was $44.9 million versus $20.1 million, and net income was $26.1 million versus $17.6 million. Diluted EPS was $0.18 versus $0.12.
- Segments: SCEM sales were $428.3 million (+2%) and segment profit $96.1 million (down from $100.4 million); AMH sales were $384.3 million (+11%) and profit $73.5 million (+11%); MC sales were $362.7 million (+15%) and profit $110.0 million, up from $83.1 million. MC was the fastest-growing segment; SCEM profit declined on mix and higher operating expenses.
Liquidity, debt, and capital allocation
- Cash and cash equivalents were $406.4 million at year-end, compared with $349.8 million; working capital was $538.6 million and the current ratio was 3.06, down from 4.04.
- Operating cash flow rose to $207.6 million. Cash used in investing activities was $66.7 million; financing activities used $81.7 million, principally reflecting $75 million of term-loan repayments. The company repurchased $7.6 million of shares in 2016.
- Debt principal was approximately $593.9 million: $233.9 million under the secured term loan and $360 million of 6% unsecured notes due 2022. Balance-sheet debt carrying value, net of discounts and issuance costs, was $584.7 million. The term loan bears variable interest; its stated rate was 3.52% at year-end.
- The $75 million asset-based revolver had no borrowings; the borrowing base was $60 million at year-end. The company reported covenant compliance. Management stated available liquidity and operating cash flow should meet ordinary domestic cash needs for the next 12 months.
- Management expects 2017 capital expenditures of approximately $80–$90 million. A new authorization for up to $100 million of share repurchases was approved on February 15, 2017. The company has not paid cash dividends and does not anticipate doing so in the foreseeable future.
Changes, outlook, and risks
- Growth reflected improved semiconductor demand, higher fab utilization and capital spending. Sales increased across AMH and MC; SCEM grew modestly. The company said its 2016 sales growth exceeded overall semiconductor industry growth.
- Management identified advanced semiconductor nodes, new materials, filtration and purification, and integrated materials-handling solutions as opportunities. It did not provide specific revenue or earnings guidance in the supplied filing text.
- Key risks include semiconductor cyclicality and limited order backlog, rapid demand shifts and forecasting risk, customer concentration (top ten customers represented 45% of sales; TSMC alone represented about 14%), pricing and competitive pressure, and dependence on some single- or limited-source suppliers.
- International sales represented 78% of revenue. Currency movements, geopolitical or trade disruption, export controls, and regulatory requirements may affect results. Other material risks include substantial debt and restrictive covenants, variable interest rates, manufacturing interruption, product liability involving hazardous-gas delivery systems, environmental compliance, and technology or customer qualification delays.
- Cash and cash equivalents included $265.6 million associated with indefinitely reinvested foreign earnings, generally subject to U.S. tax if repatriated. The filing reported no material legal proceedings expected to materially affect financial position, results, or cash flows.
- Management and the auditor concluded internal control over financial reporting was effective as of December 31, 2016; the auditor issued an unqualified opinion on the financial statements.
Important facts for investors to verify
- Whether improved semiconductor demand and the strong Q4 sales level persist, and how customer concentration and industry cyclicality affect orders.
- Whether segment profitability—particularly SCEM’s decline and MC’s improvement—continues, and how margins respond to product mix, utilization, and the 2016 impairment and severance charges.
- The company’s ability to generate cash while meeting debt service and its stated $80–$90 million 2017 capital-spending plan; review term-loan repayment expectations and covenant restrictions.
- How much of reported cash is available for domestic use, given the indefinitely reinvested foreign earnings, and whether the renewed buyback is executed.
- Whether supply constraints, regulatory changes, foreign exchange movements, or customer consolidation materially affect production, sales, or profitability.